Post-ischemic vascular adhesion protein-1 inhibition provides neuroprotection in a rat temporary middle cerebral artery occlusion model

Journal of Neurochemistry

Volumn 123, Issue SUPPL. 2, 2012, Pages 116-124

  Watcharotayangul, Jittiya ^a   Mao, Lizhen ^a   Xu, Haoliang ^a   Vetri, Francesco ^a   Baughman, Verna L ^a   Paisansathan, Chanannait ^a   Pelligrino, Dale A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

adhesion; extravasation; leukocyte trafficking; neuroprotection; neutrophil; semicarbazide sensitive amine oxidase

Indexed keywords

3 FLUORO 2 (4 METHOXYBENZYL)ALLYLAMINE; LJP 1586; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL FUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MALE; MICROSCOPY; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE FUNCTION; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SINGLE DRUG DOSE;

ALLYLAMINE; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; BRAIN INFARCTION; CELL ADHESION MOLECULES; CELL MOVEMENT; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; LASER-DOPPLER FLOWMETRY; LEUKOCYTES; MALE; MICROSCOPY, CONFOCAL; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC;

EID: 84867523880     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07950.x     Document Type: Conference Paper

References (49)

1. Aalto K., Autio A., Kiss E. A., et al,. (2011) Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be utilized in PET-imaging of inflammation and cancer. Blood 118, 3725-3733.
2. Barone F. C., and, Feuerstein G. Z., (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819-834.
3. Becker K., Kindrick D., Relton J., Harlan J., and, Winn R., (2001) Antibody to the alpha 4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32, 206-211.
4. Beray-Berthat V., Croci N., Plotkine M., and, Margaill I., (2003a) Polymorphonuclear neutrophils contribute to infarction and oxidative stress in the cortex but not in the striatum after ischemia-reperfusion in rats. Brain Res. 987, 32-38.
5. Beray-Berthat V., Palmier B., Plotkine M., and, Margaill I., (2003b) Neutrophils do not contribute to infarction, oxidative stress, and NO synthase activity in severe brain ischemia. Exp. Neurol. 182, 446-454.
6. Dunkel P., Balogh B., Meleddu R., Maccioni E., Gyires K., and, Matyus P., (2011) Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey. Expert Opin. Ther. Pat. 21, 1453-1471.
7. Engelhardt B., Vestweber D., Hallmann R., and, Schulz M., (1997) E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood 90, 4459-4472.
8. Garcia J. H., Wagner S., Liu K. F., and, Hu X. J., (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26, 627-634.
9. Gelderblom M., Leypoldt F., Steinbach K., et al,. (2009) Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40, 1849-1857.
10. Goldlust E. J., Paczynski R. P., He Y. Y., Hsu C. Y., and, Goldberg M. P., (1996) Automated measurement of infarct size with scanned images of triphenyltetrazolium chloride-stained rat brains. Stroke 27, 1657-1662.
11. Harris A. K., Ergul A., Kozak A., Machado L. S., Johnson M. H., and, Fagan S. C., (2005) Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci. 6, 49.
12. Hernandez-Guillamon M., Garcia-Bonilla L., Sole M., et al,. (2010) Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke. Stroke 41, 1528-1535.
13. Huang J., Upadhyay U. M., and, Tamargo R. J., (2006) Inflammation in stroke and focal cerebral ischemia. Surg. Neurol. 66, 232-245.
14. Hungerhuber E., Zausinger S., Westermaier T., Plesnila N., and, Schmid-Elsaesser R., (2006) Simultaneous bilateral laser Doppler fluxmetry and electrophysiological recording during middle cerebral artery occlusion in rats. J. Neurosci. Methods 154, 109-115.
15. Hurn P. D., Subramanian S., Parker S. M., Afentoulis M. E., Kaler L. J., Vandenbark A. A., and, Offner H., (2007) T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 27, 1798-1805.
16. Jalkanen S., Karikoski M., Mercier N., Koskinen K., Henttinen T., Elima K., Salmivirta K., and, Salmi M., (2007) The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 110, 1864-1870.
17. Jiang Z. J., Richardson J. S., and, Yu P. H., (2008) The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 34, 194-204.
18. Jin R., Yang G., and, Li G., (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87, 779-789.
19. Justicia C., Panes J., Sole S., Cervera A., Deulofeu R., Chamorro A., and, Planas A. M., (2003) Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J. Cereb. Blood Flow Metab. 23, 1430-1440.
20. Justicia C., Martin A., Rojas S., Gironella M., Cervera A., Panes J., Chamorro A., and, Planas A. M., (2006) Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J. Cereb. Blood Flow Metab. 26, 421-432.
21. Kassem-Moussa H., and, Graffagnino C., (2002) Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies. Arch. Neurol. 59, 1870-1873.
22. Kivi E., Elima K., Aalto K., et al,. (2009) Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Blood 114, 5385-5392.
23. Liesz A., Zhou W., Mracsko E., et al,. (2011) Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134, 704-720.
24. Lindauer U., Dreier J., Angstwurm K., Rubin I., Villringer A., Einhaupl K. M., and, Dirnagl U., (1996) Role of nitric oxide synthase inhibition in leukocyte- endothelium interaction in the rat pial microvasculature. J. Cereb. Blood Flow Metab. 16, 1143-1152.
25. Longa E. Z., Weinstein P. R., Carlson S., and, Cummins R., (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91.
26. Ma Q., Manaenko A., Khatibi N. H., Chen W., Zhang J. H., and, Tang J., (2011) Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice. J. Cereb. Blood Flow Metab. 31, 881-893.
27. Mao L., (2008) Post-ischemic treatment with the SSAO inhibitor, LJP-12078 or LJP-1586, reduces infarct volumes and improves neurologic outcomes in a rat reversible middle cerebral artery occlusion model. Soc. Neurosci. Abst. 512, 5.
28. Marsh B. J., Stevens S. L., Hunter B., and, Stenzel-Poore M. P., (2009) Inflammation and the emerging role of the toll-like receptor system in acute brain ischemia. Stroke 40, S34-S37.
29. Martin A., Rojas S., Chamorro A., Falcon C., Bargallo N., and, Planas A. M., (2006) Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Role of corticosteroids, inflammation, and protein O-glycosylation. Stroke 37, 1288-1295.
30. Meisel C., Prass K., Braun J., Victorov I., Wolf T., Megow D., Halle E., Volk H. D., Dirnagl U., and, Meisel A., (2004) Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 35, 2-6.
31. Meisel C., Schwab J. M., Prass K., Meisel A., and, Dirnagl U., (2005) Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 6, 775-786.
32. Morrison H., McKee D., and, Ritter L., (2011) Systemic neutrophil activation in a mouse model of ischemic stroke and reperfusion. Biol. Res. Nurs. 13, 154-163.
33. O'Rourke A. M., Wang E. Y., Salter-Cid L., Huang L., Miller A., Podar E., Gao H. F., Jones D. S., and, Linnik M. D., (2007) Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis. J. Neural Transm. 114, 845-849.
34. O'Rourke A. M., Wang E. Y., Miller A., et al,. (2008) Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity. J. Pharmacol. Exp. Ther. 324, 867-875.
35. Paxinos G., and, Watson C., (1997) The Rat Brain in Stereotaxic Coordinates. San Diego, Academic Press.
36. Ren X., Akiyoshi K., Dziennis S., Vandenbark A. A., Herson P. S., Hurn P. D., and, Offner H., (2011a) Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J. Neurosci. 31, 8556-8563.
37. Ren X., Akiyoshi K., Vandenbark A. A., Hurn P. D., and, Offner H., (2011b) CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab. Brain Dis. 26, 87-90.
38. Salmi M., and, Jalkanen S., (2001) VAP-1: an adhesin and an enzyme. Trends Immunol. 22, 211-216.
39. Salter-Cid L. M., Wang E., O'Rourke A. M., Miller A., Gao H., Huang L., Garcia A., and, Linnik M. D., (2005) Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. J. Pharmacol. Exp. Ther. 315, 553-562.
40. Santizo R., and, Pelligrino D. A., (1999) Estrogen reduces leukocyte adhesion in the cerebral circulation of female rats. J. Cereb. Blood Flow Metab. 19, 1061-1065.
41. Santizo R. A., Koenig H. M., and, Pelligrino D. A., (2000) Estrogen and leukocyte adhesion following transient forebrain ischemia in rats. Stroke 31, 2231-2235.
42. Santizo R. A., Xu H. L., Galea E., Muyskens S., Baughman V. L., and, Pelligrino D. A., (2002) Combined endothelial nitric oxide synthase upregulation and caveolin-1 downregulation decrease leukocyte adhesion in pial venules of ovariectomized female rats. Stroke 33, 613-616.
43. Stevens S. L., Bao J., Hollis J., Lessov N. S., Clark W. M., and, Stenzel-Poore M. P., (2002) The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res. 932, 110-119.
44. Stolen C. M., Marttila-Ichihara F., Koskinen K., Yegutkin G. G., Turja R., Bono P., Skurnik M., Hanninen A., Jalkanen S., and, Salmi M., (2005) Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity 22, 105-115.
45. Unzeta M., Sole M., Boada M., and, Hernandez M., (2007) Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease. J. Neural Transm. 114, 857-862.
46. Wang Q., Santizo R., Baughman V. L., and, Pelligrino D. A., (1999) Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 30, 630-637.
47. Warach S., and, Latour L. L., (2004) Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 35, 2659-2661.
48. Xu H. L., Galea E., Santizo R. A., Baughman V. L., and, Pelligrino D. A., (2001) The key role of caveolin-1 in estrogen-mediated regulation of endothelial nitric oxide synthase function in cerebral arterioles in vivo. J. Cereb. Blood Flow Metab. 21, 907-913.
49. Xu H. L., Salter-Cid L., Linnik M. D., Wang E. Y., Paisansathan C., and, Pelligrino D. A., (2006) Vascular adhesion protein-1 plays an important role in postischemic inflammation and neuropathology in diabetic, estrogen-treated ovariectomized female rats subjected to transient forebrain ischemia. J. Pharmacol. Exp. Ther. 317, 19-29.